Showing 1 - 10 of 7,451
The UK's withdrawal from the European Union will have – and already has – a dramatic impact on the political, legal and economic landscape, both in Britain and on the continent. This contribution takes a closer look at the effects on individual relationships and businesses. Against the...
Persistent link: https://www.econbiz.de/10012968102
This commentary focuses on Article 8.30 CETA, which is entitled ‘Ethics’ and sets ethical rules for the Members of the CETA Tribunal and the Appellate Tribunal. The European Commission presents this precept in a succinct paragraph, highlighting the key issues addressed and the main novelties...
Persistent link: https://www.econbiz.de/10014242634
The Transatlantic Trade and Investment Partnership (TTIP) presents an historic opportunity for the European Union and the United States to remove regulatory divergence – today's most prominent obstacle to trade exchanges –, thereby increasing economic growth for the citizens of both...
Persistent link: https://www.econbiz.de/10013055632
Persistent link: https://www.econbiz.de/10014337053
Persistent link: https://www.econbiz.de/10003936496
Persistent link: https://www.econbiz.de/10012387951
-centralized avenues for dialogue among various stakeholders to influence domestic regulation, especially in areas of environmental … regulation, energy, and sustainable development. The paper argues that this trend has led toward the institutionalization of … together to implement regulation, this trend could take yet another turn — one that centralizes decisions regarding regulation …
Persistent link: https://www.econbiz.de/10012927605
regulation can crowd out voluntary private efforts, thereby diminishing their effectiveness and legitimacy; and the second …, countervailing argument that Fair Trade systems and regulation can be complimentary and mutually reinforcing. It then discusses ways … areas of safety, discrimination, and environmental regulation …
Persistent link: https://www.econbiz.de/10014194838
This paper explores the massive strides that were made in response to the COVID-19 pandemic by national drug regulatory agencies (NRAs) in order to achieve what ultimately became the fastest incidence in human history of the development, testing, approval, manufacture, and distribution of a new...
Persistent link: https://www.econbiz.de/10014077111